David P. Southwell - May 18, 2022 Form 4 Insider Report for TScan Therapeutics, Inc. (TCRX)

Signature
/s/ David P. Southwell
Stock symbol
TCRX
Transactions as of
May 18, 2022
Transactions value $
$89,821
Form type
4
Date filed
5/20/2022, 04:15 PM
Previous filing
Jan 20, 2022
Next filing
Jun 15, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TCRX Voting Common Stock Purchase $54.3K +15K +10.23% $3.62 162K May 18, 2022 Direct F1
transaction TCRX Voting Common Stock Purchase $35.5K +10K +6.19% $3.55 172K May 18, 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $3.379 to $3.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the ranges set forth in this footnote.
F2 The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $3.45 to $3.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the ranges set forth in this footnote.